Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 69  |  Page : 321-328

Comparison of anti-inflammatory efficacy between dexamethasone and a standardized herbal formula, PM014, in a cigarette smoke-induced subacute mouse model of chronic obstructive pulmonary disease


Division of Allergy, Immune and Respiratory System, Department of Internal Medicine, College of Korean Medicine, Kyung Hee University, KyungHeedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea

Correspondence Address:
Beom-Joon Lee
Department of Internal Medicine (Pulmonary and Allergy System), Korean Medicine Hospital, 23, Kyung Hee Dae-ro, Dongdaemun-gu, Seoul 130-872
Republic of Korea
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_222_19

Rights and Permissions

Objective: A standardized herbal formula, PM014, originated from Chungsangboha -tang, which has been used to treat various respiratory diseases, including bronchitis, asthma, and emphysema. Several previous studies have reported that the therapeutic mechanism of PM014 was mediated by an anti-inflammatory effect. Therefore, we compared anti-inflammatory efficacy between PM014 and dexamethasone (DEX) using a mouse model of cigarette smoke (CS)-induced subacute pulmonary inflammation. Materials and Methods: Female C57BL/6 mice were revealed to CS for 2 h/day, three cigarettes per day, 5 days a week for 3 weeks; the control group got no other treatment, while the DEX and PM014 groups received 1 mg/kg of DEX and 100 mg/kg of PM014, respectively (both were orally administered). The histological morphology and average alveolar size were determined by lung histology. The inflammatory cell profiles and protein expressions of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1 β, IL-6, and one pro-inflammatory chemokine (monocyte chemoattractant protein 1 [MCP-1]), were measured in bronchoalveolar lavage fluid (BALF). The mRNA expressions of the pro-inflammatory cytokines and chemokine were also measured in lung tissues. Results: Both PM014 and DEX attenuated histological injury and air space enlargement in lung tissue and decreased the number of inflammatory cells in BALF. Both also decreased the mRNA expressions of TNF-α, IL-6, and IL-1 β in lung tissue and reduced the protein expressions of TNF-α, IL-1 β, IL-6, and MCP-1 in BALF. Conclusion: Our results showed that the anti-inflammatory efficacy of PM014 and DEX was equivalent in a subacute mouse model of CS-induced chronic obstructive pulmonary disease.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed40    
    Printed3    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal